Takeda Pharmaceutical Company Limited
TKPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12 | $124 | -$103 | $24 |
| Dep. & Amort. | $185 | $182 | $190 | $187 |
| Deferred Tax | $40 | $26 | -$4 | $3 |
| Stock-Based Comp. | $19 | $17 | $18 | $18 |
| Change in WC | $22 | -$34 | $3 | $89 |
| Other Non-Cash | $124 | -$100 | $119 | $63 |
| Operating Cash Flow | $378 | $215 | $222 | $384 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$40 | -$48 | -$49 | -$45 |
| Net Acquisitions | $0 | $29 | $68 | $1 |
| Inv. Purchases | -$2 | -$0 | -$2 | -$68 |
| Inv. Sales/Matur. | $3 | $1 | $3 | $4 |
| Other Inv. Act. | -$10 | -$15 | -$39 | -$8 |
| Investing Cash Flow | -$48 | -$33 | -$20 | -$116 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $37 | $0 | -$204 | -$471 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$52 | -$50 | $0 |
| Dividends Paid | -$9 | -$145 | -$10 | -$145 |
| Other Fin. Act. | -$40 | -$18 | -$39 | -$40 |
| Financing Cash Flow | -$12 | -$215 | -$302 | -$656 |
| Forex Effect | $13 | -$2 | -$10 | $23 |
| Net Chg. in Cash | $331 | -$35 | -$109 | -$365 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $350 | $385 | $494 | $859 |
| End Cash | $681 | $350 | $385 | $494 |
| Free Cash Flow | $325 | $140 | $129 | $327 |